Raymond James & Associates’s Progyny PGNY Stock Holding History
Bought
Maintained
Sold
Other funds holding PGNY
TGA
FAM
ICM
Raymond James & Associates's PGNY Position: Q3 2024 in Review
Raymond James & Associates reduced its Progyny (PGNY) stake by 78% in Q3 2024, selling an estimated $1.25M and leaving 14,974 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #3504.
Raymond James & Associates first reported a position in PGNY in Q4 2019 and has held it in 19 quarters since. The position peaked at $4.99M in Q2 2021. 285 funds tracked by Wall St. Rank hold PGNY as of Q3 2024.
- Raymond James & Associates held 14,974 shares of Progyny worth $251K as of Q3 2024.
- Raymond James & Associates sold 52,188 Progyny shares in Q3 2024, an estimated $1.25M.
- Progyny made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3504 holding.
- Raymond James & Associates first reported a position in Progyny in Q4 2019 and has held it in 19 quarters since.
- Raymond James & Associates's Progyny position peaked at $4.99M in Q2 2021.
- 285 funds tracked by Wall St. Rank held Progyny as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.